Integrated Diagnostic for Heart Failure

Patients with systolic heart failure (HF) implanted with Medtronic wireless implantable cardiac defibrillator (ICD) or cardiac resynchronization therapy device with defibrillation capabilities (CRT-D) devices will be enrolled in the study. The purpose of the study is to evaluate the usability of CareLink HFRS to manage a patient's heart failure.

Inclusion criteria

• Patient is 18 years of age or older
• Patient ( or patient's legally authorized representative) is willing and able to provide written informed consent
• Patient is willing and able to comply with the required study follow up visits
• Patient is implanted with a Medtronic wireless ICD or CRT-D device capable of OptiVol fluid monitoring feature
• Patient is on Medtronic CareLink network or is willing to be enrolled on the CareLink network
• Patient is being managed, or has been managed, by a HF clinician
• Patient has signed an informed consent for CareLink Network Services
• Patient is implanted with device for at least three months
• Patient is willing and able to transmit data using the CareLink home monitor (2490C).

Exclusion criteria

• Patient is participating in another study that may interfere with TRIAGE-HF protocol required procedures
• Patient with an implantable cardiac device that is indicated to reach ERI in less than 12 months